performed beforehand. 4, 5 Blood samples can be taken just before and even during irradiation to measure the tissue boron concentration, assuming the tumour/blood ratios assessed in previous biodistribution studies. However the boron distribution varies among patients and therefore large uncertainties exist in the tumour-to-blood boron concentration ratio. The recent development of more sensitive imaging techniques and molecular medicine protocols, based on the use of site specific agents able to carry large amounts of both therapeutic and diagnostic agents, can contribute to enhance BNCT efficacy and to become more competitive with the established tumour treatment protocols. 6 Among the compounds developed for BNCT, much attention has been devoted to carboranes, icosahedral cages containing several boron atoms, which could increase the payload of boron in the tumour cells. [7] [8] [9] [10] Boron containing compounds can be further functionalized with lipophilic moieties in order to permit their specific and efficient delivery through the incorporation in targeted nanoparticles. The synthesis of new dual agents for applications in MRI/BNCT where a carborane unit is linked to a lipophilic chain and to a Gd-DOTA complex through amidic bonds has been developed in our laboratory (AT101).
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According to the synthetic design, the lipophilic probe AT101 binds to LDLs (Low Density Lipoproteins) and accumulates at tumor cells characterized by an up-regulation of LDL transporters. The exploitation of LDL as biological vectors was indeed the key to obtain a high concentration of B atoms/g at the tumor cells together with a good selectivity between tumor and healthy tissues. In vivo MR images acquisition showed that the amount of boron taken up in the tumor region was above the threshold required for a successful NCT treatment. More recently, with the purpose of simplifying the synthetic procedure but maintaining, and possibly improving, the favorable properties of AT101, we designed a new structure containing a triazole linker instead of the amidic function (MEA/01). 12 Its adducts were tested "in vitro" on B16 melanoma cells and the obtained intracellular Gd/B concentration appears sufficient for further "in vivo" BNCT studies.
An alternative promising approach to deliver efficiently boron containing agents to tumors consists of the use of liposomes. In fact, there are many examples in the literature of formulations containing boron compounds encapsulated into the aqueous cavity or, after conjugation with lipids, incorporated into the liposomal bilayer. [13] [14] [15] A specific class of liposomes, named "long time circulating" polyethylene glycol (PEG)-coated liposomes, is able to accumulate in solid tumors as a consequence of microvascular permeability and defective lymphatic drainage. [16] [17] [18] The extent of passive extravasation is directly dependent on the prolonged residence time of liposomes in the blood stream. As far as the internalization step is concerned one should note that in the absence of a receptor mediated mechanism, the internalization of the intact liposome into tumor cells does not take place. Therefore, in the absence of liposome active targeting the boron containing molecule has first to be released in the tumor extracellular matrix in order to allow its diffusion into cells.
Alternatively, the active targeting of liposomes to tumor cells is obviously a promising strategy to improve drug delivery to tumors. To this purpose, liposomes have to be functionalized with specific ligands able to bind and to internalize through receptors expressed on tumor vasculature or on tumor cells. Recently, Nakamura and co-workers developed liposomes containing mercaptoundecahydrododecaborate (BSH) in the inner aqueous cavity and 10% distearoyl boron lipid (DSBL) incorporated in the phospholipid bilayer. 19, 20 The proposed system appears particularly efficient because the liposome shell itself contains boron in addition to the boron encapsulated in the aqueous cavity. Furthermore, they performed the in vivo real-time tracking of 10% DSBL liposomes by MRI using liposomes encapsulating Gd-DOTA, observing a high signal intensity enhancement in the tumor region. The disadvantage of the use of therapeutic and imaging agents as independent molecules, is that they maintain the same biodistribution only if the liposome remains intact. After liposome degradation their biodistribution will be different and dependent on their size, hydrophilic character, residual charges, etc… In order to overcome this problem, in this study, a dual agent in which the imaging (Gd-DOTA) and the BNCT (carborane) components are part of the same molecule, is proposed. The incorporation of the molecule in the liposome bilayer has been pursued by a functionalization with a cholesterol residue. Cholesterol is a standard component of the liposome bi-layer usually introduced in the phospholipid formulation in order to increase the particle stability. On the contrary, complexes bearing only a palmitic chain, as the parent AT101 previously investigated by our group, can not be steadily incorporated in the liposome bi-layer and the complex may be releazed randomly. Despite the harsh applied conditions, the product was obtained in 27% yield after chromatographic purification, because of the steric hindrance of the alcoholic group. Alcohol 2 was then oxidized to the corresponding carboxylic acid, following the classical Jones reaction conditions with an overall yield of 78%. The formation of 3-(Cholesten-5-en-3-yloxy)-propionic acid (3,Scheme 1) was confirmed by the detection of a resonance at 170 ppm in the 13 C spectrum pertinent to the carbonyl group. The COOH moiety was then coupled to C-(2-benzyloxy)-ethyl-C'-aminomethyl-o-carborane 7 (prepared as previously reported). 11 Firstly, the coupling was attempted according to the procedure proposed by Kamiński, 23 but the desired product was not obtained. A two-step protocol, where the acid was activated with N-hydroxysuccinimide (NHS) in the presence of DCC was then applied with the formation of product 4 (64% yield after chromatograhic purification). 1 H NMR analysis confirmed the proposed structure. In particular the resonance of the α-methylenic group shifted from 3.39 ppm in the amino derivative 7 to 4.06 ppm in the coupling product.
At this point the functionalization of the other arm of the o-carborane has been tackled. As reported in Scheme 2, the benzylic protecting group was selectively removed by Pd/C catalyzed hydrogenation. 24 Different catalyst concentrations and solvents were tested in order to avoid the concomitant hydrogenation of the cholesterol double bond. It was found that 5% of Pd/C in EtOH/CH 2 Cl 2 2/1 provide the best conditions, affording after 24 h the desired product 5 in 92% overall yield.
Alcohol 5 was readily oxidized to the corrisponding carboxylic acid 6 by CrO 3 in acetonesulfuric acid solution (scheme 2).
The structure of derivative 6 was supported by the 1 H and 13 C NMR data. The 1 H NMR spectrum showed the disappearance of the signal at 3.75 ppm assigned to the HOCH 2 -group, with the concomitant growth in the 13 C NMR spectrum, of the signal at 172 ppm corresponding to the carbonyl group.
In order to obtain the molecule containing both the BNCT and the MRI moieties, derivative 6
was reacted with N-terbutyl-DOTAMA-C 6 -NH 2 using the two-step procedure previously
described for the preparation of C-(2-benzyloxyethyl)-C'-[cholesten-5-en-3-yloxy-(3-
propionacetoamidomethyl)]-o-carborane (4) (Scheme 2). Carborane 6 was then activated via NHS in the presence of DCC and after filtration of DCU, reacted with the suitable amine In order to assess whether the amount of Gd internalized in target cells is enough to permit MRI visualization, T 1 weighted images of glass capillaries containing cellular pellets obtained by incubating ca. 1x10 6 IGROV cells with increasing amounts of targeted and non targeted Gd-B-AC01/liposomes were acquired at 1 and 7 T (Figure 3) . At 1 T, there is a dominant effect of the long reorientational motion of the paramagnetic macromolecule that causes a dramatic relaxation rate increase with a consequent signal intensity enhancement increase as shown in the NMRD profiles of figure 1 . Clearly, the SI enhancements of labeled cells measured at 1 T (SI=80% after 5M Gd incubation) were markedly higher than those measured at 7 T (SI=45% after 5uM Gd incubation). The mean SI enhancement (%) of the target tissues was calculated according to the Equation (1):
The recorded SI of targeted liposome in both cell lines is higher in respect to non-targeted ones.
This demonstrates the specific accumulation of folate targeted liposomes in tumor cells with respect to control liposomes. The amount of internalized boron measured by ICP-MS was 38 and 9 ppm for folate-targeted and non-targeted liposomes, respectively. The former amount is significantly higher than the minimum boron concentration necessary to perform BNCT. We can conclude that Gd-B- Although the cells have not been completely killed, the purpose of the experiments has been satisfied because these measurements were meant to verify that the new formulations had a potentiality as vectors for BNCT. Further studies with dose escalation are planned.
Conclusions.
In summary, the dual MRI/BNCT probe described in this paper can be exploited to accumulate B 
EXPERIMENTAL PROCEDURES General Methods
Flasks and all equipments used for the generation and reaction of moisture-sensitive compounds were dried by electric heater under Ar. THF was distilled from benzophenone ketyl, anhydrous = doublet, t = triplet, q = quartet, dd = double-doublet, m = multiplet, br = broad), coupling constants (Hz), and assignment. 13 
-(2-benzyloxyethyl)-C'-aminomethyl-o-
carborane (7) and N-tert-ButylDOTAMA-C 6 -NH 2 were synthesized as described in literature and their spectroscopic data corresponded with those reported. (2) 
3-((3β)-colest-5-en-3-yloxy)-propanol (2

3-(Cholesten-5-en-3-yloxy)-propionic acid (3). 3-((3β)-colest-5-en-3-oxy)-propanol
C-(2-Benzyloxyethyl)-C'-[cholesten-5-en-3-yloxy-(3-propionacetoamidomethyl)]-o-carborane (4).
In a 100 mL three necked round bottom flask, 3-(cholesten-5-en-3-yloxy)-propionic acid (3) (1.27 mmol, 0.58 g) was dissolved in 40 mL of dry 
C-(Hydroxyethyl)-C'-[cholesten-5-en-3-yloxy-(3-propionacetoamidomethyl)]-o-carborane (5)
In a 50 mL two necked round bottom flask, C-(2-Benzyloxyethyl)-C'-[cholesten-5-en-3-yloxy-(3-
propionacetoamidomethyl)]-o-carborane (4) (0.18 g, 0.24 mmol) was dissolved in 20 mL of a mixture of EtOH-CH 2 Cl 2 (50-50), then Pd/C (10%) was wet with few drops of water and added.
The reaction mixture was stirred overnight at rt in a H 2 saturated atmosphere, then filtered and the solvent was evaporated under reduced pressure giving 0.14 g (88 %) of a white solid. M.p.= [ Liposome preparation and characterization. μs at 160 V) with a field homogeneity of 0.2-0.5 gauss. MR images at 7T were acquired on a Bruker Avance300 spectrometer equipped with a Micro 2.5 microimaging probe (Bruker BioSpin, Ettlingen, Germany) using two birdcage resonators with 30 and 10 mm inner diameter.
Gd(III)-C-[N-(DOTAMA-
For recording MR images in vitro, cells were centrifuged at the bottom of glass capillaries placed in a phantom embedded of high gelling agarose gel (1% in PBS). MR images were acquired using a standard T1weighted multislice spin echo sequence, using the following parameters: TR/TE/NEX 250/4/6, resolution 78 μm, slice thickness 1 mm at 7 T and TR/TE/NEX 250/7/16, resolution 78 μm, slice thickness 1 mm at 1 T, respectively. At both field strengths a standard saturation recovery protocol was used to measure T1 relaxation times.
Cells irradiation
Seven flasks, four with IGROV-1 cells previously incubated for 24h in presence of folate targeted GdAC01/liposomes, at a 10M Gd concentration, and three with non-treated control cells were irradiated in the thermal column of the TRIGA Mark II reactor at University of Pavia, Italy. The cells cultured in presence of liposomes were washed with cold PBS before irradiation. At the end of the irradiation, the medium was removed, it was replaced with RPMI and flasks were placed at 37 °C in a humidified atmosphere of 5% CO 2 .
The irradiation position had been previously characterized from the point of view of neutron flux distribution by means of thin activation foils. 35 The authors declare no competing financial interest.
